Author: Marriott, Andrew S.; Vasieva, Olga; Fang, Yongxiang; Copeland, Nikki A.; McLennan, Alexander G.; Jones, Nigel J.
Title: NUDT2 Disruption Elevates Diadenosine Tetraphosphate (Ap(4)A) and Down-Regulates Immune Response and Cancer Promotion Genes Document date: 2016_5_4
ID: 0ozzbp85_31
Snippet: There is strong evidence that Trp catabolism and IDO1 expression in dendritic cells, which have a myeloid lineage, are important for the suppression of T-cell responses and the promotion of immune tolerance [73] . The reduction of extracellular Trp, the generation of metabolites via the kynurenine pathway and the signaling function of tyrosine-phosphorylated IDO1 all contribute to immunosuppression and protection against autoimmune disease and al.....
Document: There is strong evidence that Trp catabolism and IDO1 expression in dendritic cells, which have a myeloid lineage, are important for the suppression of T-cell responses and the promotion of immune tolerance [73] . The reduction of extracellular Trp, the generation of metabolites via the kynurenine pathway and the signaling function of tyrosine-phosphorylated IDO1 all contribute to immunosuppression and protection against autoimmune disease and allograft rejection by inhibiting the proliferation of T cells and NK cells and promoting autophagy and anergy [74, 75] . The strong down-regulation of Trp catabolism caused by elevated Ap 4 A would therefore be expected to promote T-cell responses and suppress tolerance. This is consistent with the up-regulation of adaptive immune functions in NuKO cells predicted by IPA 1 (Table 4 ). Furthermore, overexpression of IMPACT, an inhibitor of the GCN2-kinase (EIF2AK4) stress-signaling pathway that represses translation and proliferation in response to amino acid starvation, protects T-cells from Trp depletion [76] . IMPACT is up-regulated 13-fold in NuKO cells (S3 Table) and this would contribute further to the promotion of T-cell responses if reproduced in T cells.
Search related documents:
Co phrase search for related documents- allograft rejection and autoimmune disease: 1
- allograft rejection and dendritic cell: 1
- allograft rejection and immune tolerance: 1
- allograft rejection and NK cell: 1, 2, 3
- allograft rejection autoimmune disease and autoimmune disease: 1
- allograft rejection autoimmune disease and NK cell: 1
- autoimmune disease and dendritic cell: 1, 2
- autoimmune disease and immune function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- autoimmune disease and immune tolerance: 1, 2, 3, 4, 5, 6, 7
- autoimmune disease and kynurenine pathway: 1
- autoimmune disease and NK cell: 1, 2, 3
- dendritic cell and immune function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- dendritic cell and immune tolerance: 1, 2, 3, 4
- dendritic cell and NK cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- immune function and myeloid lineage: 1
- immune function and NK cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- immune tolerance and kynurenine pathway: 1
- immune tolerance and NK cell: 1, 2, 3
- myeloid lineage and NK cell: 1, 2
Co phrase search for related documents, hyperlinks ordered by date